Skip to main content
WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS · Delayed Price · Currency is USD
5.80
-0.15 (-2.52%)
Apr 25, 2025, 3:53 PM EDT

WuXi Biologics Revenue

In the year 2024, WuXi Biologics had annual revenue of 18.68B CNY with 9.63% growth. WuXi Biologics had revenue of 10.10B in the half year ending December 31, 2024, with 25.29% growth.

Revenue
18.68B CNY
Revenue Growth
+9.63%
P/S Ratio
4.65
Revenue / Employee
1.49M CNY
Employees
12,575
Market Cap
11.91B USD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202418.68B1.64B9.63%
Dec 31, 202317.03B1.77B11.56%
Dec 31, 202215.27B4.98B48.38%
Dec 31, 202110.29B4.68B83.35%
Dec 31, 20205.61B1.63B40.88%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
Veradigm 588.02M
Glass House Brands 200.90M
Northwest Biotherapeutics 1.38M
Elite Pharmaceuticals 70.00M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Silence Therapeutics 43.26M
Revenue Rankings

WuXi Biologics News

More News